TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2011

Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).

Aminah Jatoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.